Status:
COMPLETED
Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients
Lead Sponsor:
The Institute of Molecular and Translational Medicine, Czech Republic
Conditions:
Colorectal Cancer
Circulating Tumor Cell
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To determine whether the presence of circulating/disseminated tumor cells (CTCs/DTCs) in the blood and bone marrow of colorectal cancer (CRC) patients with localized disease is a negative prognostic f...
Eligibility Criteria
Inclusion
- \- colorectal adenocarcinoma
Exclusion
- prior neoadjuvant chemoradiotherapy
- prior colorectal cancer
- cancer duplicity
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 23 2015
Estimated Enrollment :
256 Patients enrolled
Trial Details
Trial ID
NCT03337347
Start Date
January 1 2004
End Date
October 23 2015
Last Update
October 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Olomouc
Olomouc, Czechia, 77900